Kappos L, et al. Efficacy and safety of ponesimod compared to teriflunomide in patients with relapsing multiple sclerosis: results of the randomized, active-controlled, double-blind, parallel-group phase 3 OPTIMUM study. Abstract 93. ECTRIMS 2019, 11-13 sept 2019, Stockholm, Zweden.
Onderliggende oorzaken TIA en minor stroke beïnvloeden risico ernstig vasculair event
dec 2023 | Atherosclerose, Neuro-vasculair